PubNub Powers Historic FIFA Club World Cup 2025™ Broadcast with DAZN, Creating the World’s Largest Virtual Fan Experience

27.8.2025 14:00:00 CEST | Business Wire | Press Release

PubNub, the leading platform for real-time interactive applications, announced its collaboration with DAZN, the leading global sports entertainment platform, to power a groundbreaking broadcast of the FIFA Club World Cup 2025™. This was the first men’s international club football tournament streamed live and free to fans worldwide. Leveraging PubNub’s real-time infrastructure, DAZN delivered an interactive global viewing experience to millions of fans across 63 matches in 30 days.

Breaking New Ground in Sports Broadcasting

The tournament featured 32 of the world’s top clubs and reached over 200 markets. PubNub’s infrastructure enabled DAZN to go beyond streaming, recreating the excitement of stadium energy in living rooms worldwide.

“DAZN didn’t just want to stream matches — they wanted to recreate the electric atmosphere of being there,” said Todd Greene, CEO of PubNub. “This required a robust real-time infrastructure that could scale while keeping interactions instant, seamless, and engaging. The results speak for themselves — we created the world's largest virtual fan experience with DAZN.”

Robust Real-Time Infrastructure

Throughout the tournament, PubNub powered exceptional performance, including:

212 million requests per minute at peak
99.999% uptime across all matches
Sub-100ms latency ensuring instant fan interactions
Zero interruptions during the entire 30-day event

The World’s Largest Virtual Fan Experience

By combining DAZN’s platform with PubNub’s technology, passive viewers became members of a vibrant community. Features included:

Responsive real-time chat with millions of participants
Instant live reactions visible across all devices
Social viewing for friends to watch together globally
Multi-screen synchronized experiences
Actionable insights from fan engagement, powering highlight reels and social content

“Fans weren’t just watching,” Greene added. “They were celebrating goals together and creating shared memories beyond the 90 minutes of play.”

The Future of Sports Broadcasting

The success of the FIFA Club World Cup 2025™ broadcast highlights rising demand for interactive digital sports experiences. PubNub and DAZN proved that streaming platforms can replicate stadium energy while opening new fan engagement and revenue opportunities.

“DAZN showed that streaming can rival in-person experiences,” said Greene. “This sets the standard for immersive, interactive broadcasting moving forward.”

About PubNub

PubNub is the world’s leading real-time communication platform, powering interactive experiences across gaming, healthcare, education, retail, and media. PubNub enables developers to build applications with sub-100ms latency, 99.999% reliability, and global scale. Learn more at www.pubnub.com.

About DAZN

DAZN is the leading sports entertainment platform, streaming live and on-demand content to millions of fans worldwide. As the exclusive broadcaster for the FIFA Club World Cup 2025™, DAZN made history by delivering the tournament free to fans in over 200 markets. Visit www.dazn.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250827089247/en/

Contacts

Media Contact:
Kayley Smith, Marketing Director
PubNub | 737-328-9825 | kayley.smith@pubnub.com

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release

Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom